Efficacy of Multi-waved Locked System Laser Versus Cold Compression Therapy on Breast Cancer-related Lymphoedema

NCT05911854 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2023-06-22

No results posted yet for this study

Summary

This study was conducted:

* To investigate the effect of MLS Laser in the management of patients with unilateral BCRL regarding lymphatic flow, volumetric measurement and HRQL assessment.
* To investigate the effect of CCT in the management of patients with unilateral BCRL regarding lymphatic flow, volumetric measurement and HRQL assessment.
* To compare the effect of MLS Laser versus CCT in the management of patients with unilateral BCRL regarding lymphatic flow, volumetric measurement and HRQL assessment.

Conditions

  • Lymphedema

Interventions

DEVICE

Multi-waved Locked System Laser

The M6 therapy laser is a robotized multi-target device designed to treat patients suffering pathologies affecting a wide area, and to perform automatic applications.

DEVICE

Cold Compression therapy

The BioCryo Cold Compression System is a cold therapy pneumatic compression device that safely administers sequential, gradient pneumatic compression and CryoTherapy combined.

OTHER

complete decongestive therapy

Complete decongestive therapy consists of: * Meticulous skin care with the use of emollients * Using short stretch bandages or continuous wearing of a pressure garment * Manual lymphatic drainage therapy * Remedial exercises (e.g., aerobic exercise, strength training, and stretching exercises)

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Mohamed H El-Gendy, professor · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-21
Primary Completion
2023-05-06
Completion
2023-06-05

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05911854 on ClinicalTrials.gov